Consultation

●The following persons should contact a physician, pharmacist, or registered salesperson for a consultation before administration.

1. Patients undergoing medical treatment from a physician or dentist.

2. Pregnant women or women suspected of being pregnant.

3. Patients who have experienced allergic symptoms associated with drugs, etc. Persons with the following symptoms: hyperthermia, urination difficulty

4. Persons diagnosed as having the following heart disease

Liver disease

Kidney disease

Gastric/duodenal ulcer

Glaucoma

Respiratory functional disorder, obstructive sleep apnea syndrome, adiposity

●If the following symptoms are observed after taking this drug, these may be adverse reactions, so immediately discontinue the use of this drug, and show this document to your physician, pharmacist, or registered salesperson for a consultation.

1. Affected area: Skin

Symptoms: rash/redness, itching

2. Affected area: Gastrointestinal system

Symptoms: nausea/vomiting, loss of appetite, feeling of discomfort in the stomach, stomach ache, abdominal pain, feeling of stomach/abdominal distention, heartburn, and diarrhea

3. Affected area: Neuropsychiatric system

Symptoms: dizziness, numbness

3. Affected area: Urinary system:

Symptoms: urination difficulty

4. Other: oedema, excessive temperature decrease

●The following serious symptoms may occur in rare cases. In such cases, immediately seek medical aid from a physician.

1. Condition: Shock (anaphylaxis)

Symptoms: such as itching of skin, urticaria, hoarseness, sneezing, itchy throat, breathing difficulties, palpitations, and clouding of consciousness may occur immediately after take.

2. Condition: oculomucocutaneous syndrome (Stevens-Johnson syndrome), toxic epidermal necrolysis, acute generalised exanthematous pustulosis

Symptoms: Hyperthermia, ocular hyperaemia, eye discharge, lip erosion, pain throat, widespread skin rash/redness, small pimples (small pustules) on reddened skin, general malaise, anorexia, etc. may persist or suddenly worsen.

3. Condition: Hepatic function failure

Symptoms: such as fever, itching, rash, jaundice (yellowing of skin and white of eyes), brown urine, general malaise, loss of appetite, etc. may occur.

Ingredient and amount

In 2 tablets

Ambroxol hydrochloride 15mg

L-carbocysteine 250mg

Ihydrocodeine Phosphate 8mg

Acetaminophen 300mg

Chlorpheniramine Maleate 2.5mg

Riboflavin 4mg

Relief of various symptoms of a common cold: running nose, stuffy nose, sneezing, sore throat, cough, phlegm (sputum), chills (feeling cold due to fever), fever, headache, joint pain, and muscle pain.

●Dosage and administration

Take the following dose with cold or lukewarm water within 30 minutes after a meal whenever possible. 15 years or over: 2 tablets per dose, 3 times daily

Children aged 12–14 years old: 1 tablet, 3 times a day

Children under 12 years old: Do not take this drug.

・Comply with the prescribed dosage and administration instructions.

・The use of the drug in children should be supervised by a parent.

・Do not return the tablets touched by wet fingers into the jar. (It will cause discoloration and may deteriorate the quality.

●Other ingredients: cellulose, anhydrous silicic acid, calcium hydrogen phosphate, sodium starch glycolate, hydroxypropylcellulose, hardened oil, magnesium stearate

●Precautions relating to ingredient and amount

No need to worry if you have yellow urine after taking the drug because it is caused by the vitamin B2 contained in the drug.

Consultation

●The following persons should contact a physician, pharmacist, or registered salesperson for a consultation before administration.

1. Patients undergoing medical treatment from a physician or dentist.

2. Pregnant women or women suspected of being pregnant.

3. Patients who have experienced allergic symptoms associated with drugs, etc. Persons with the following symptoms: hyperthermia, urination difficulty

4. Persons diagnosed as having the following heart disease

Liver disease

Kidney disease

Gastric/duodenal ulcer

Glaucoma

Respiratory functional disorder, obstructive sleep apnea syndrome, adiposity

●If the following symptoms are observed after taking this drug, these may be adverse reactions, so immediately discontinue the use of this drug, and show this document to your physician, pharmacist, or registered salesperson for a consultation.

1. Affected area: Skin

Symptoms: rash/redness, itching

2. Affected area: Gastrointestinal system

Symptoms: nausea/vomiting, loss of appetite, feeling of discomfort in the stomach, stomach ache, abdominal pain, feeling of stomach/abdominal distention, heartburn, and diarrhea

3. Affected area: Neuropsychiatric system

Symptoms: dizziness, numbness

3. Affected area: Urinary system:

Symptoms: urination difficulty

4. Other: oedema, excessive temperature decrease

●The following serious symptoms may occur in rare cases. In such cases, immediately seek medical aid from a physician.

1. Condition: Shock (anaphylaxis)

Symptoms: such as itching of skin, urticaria, hoarseness, sneezing, itchy throat, breathing difficulties, palpitations, and clouding of consciousness may occur immediately after take.

2. Condition: oculomucocutaneous syndrome (Stevens-Johnson syndrome), toxic epidermal necrolysis, acute generalised exanthematous pustulosis

Symptoms: Hyperthermia, ocular hyperaemia, eye discharge, lip erosion, pain throat, widespread skin rash/redness, small pimples (small pustules) on reddened skin, general malaise, anorexia, etc. may persist or suddenly worsen.

3. Condition: Hepatic function failure

Symptoms: such as fever, itching, rash, jaundice (yellowing of skin and white of eyes), brown urine, general malaise, loss of appetite, etc. may occur.

Taisho Pharmaceutical Co., Ltd.

3-24-1, Takada, Toyodhima-ku, Tokyo

03-3985-1800

8:30~21:00 (excluding Saturdays, Sundays and holidays)